Asker Healthcare Group Expands UK Presence with Acquisition of Novus Med
Asker Healthcare Group has acquired 100% of the shares in Novus Med Holdings Limited, a leading niche distributor of solutions in endoscopic surgical technology and patient positioning in the UK. This strategic move strengthens Asker’s footprint in the British healthcare market.
Johan Falk, CEO of Asker Healthcare Group, commented on the acquisition: “Novus Med is an excellent complement to HSL Group’s existing presence and customer offering within both surgery and outpatient care in the UK. Through the acquisition, we add new and innovative technologies within minimally invasive procedures and become a more comprehensive partner to hospitals in the country. We are pleased to welcome the professional team from Novus Med, whose commitment to quality and improved healthcare outcomes will fit very well into HSL Group and the rest of the Asker family.”
Key Highlights of the Acquisition:
- Strategic Fit: Novus Med aligns perfectly with HSL Group’s existing operations in the UK.
- Technological Advancement: The acquisition brings innovative technologies in minimally invasive procedures.
- Team Integration: Novus Med’s team is expected to integrate seamlessly into the HSL Group and Asker Healthcare Group.
Novus Med, based in the UK, has 12 employees and generated a turnover of approximately SEK 80 million during its most recent financial year, which ended in June 2025.
Financial Impact
The acquisition is an add-on acquisition to HSL Group and is expected to contribute positively to the group’s EBITA margin.
About Asker Healthcare Group
Asker Healthcare Group partners with healthcare providers and patients in Europe within medical technology products and services. They develop and acquire leading companies that support healthcare in improving outcomes, reducing total costs, and ensuring a fair and sustainable value chain. The group has over 4,500 employees in 18 countries and a turnover of SEK 16 billion.
Enjoyed this post by Thibault Helle? Subscribe for more insights and updates straight from the source.
